Tech Company Financing Transactions
Lassogen Funding Round
Playground Global, Better Ventures and First In Ventures participated in a $4.5 million Seed capital raise for Lassogen. This venture round was announced on 10/14/2020.
Transaction Overview
Company Name
Announced On
10/14/2020
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Seed
Investors
Playground Global (Lead Investor) (Phyllis Whiteley)
Proceeds Purpose
The company intends to use the funds to achieve key results that demonstrate the utility and promise of lasso peptides for treating serious human diseases such as cancer, autoimmunity, pain, and inflammation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4757 Nexus Center Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a new therapeutic modality for diagnosing and treating some of our most intractable health challenges. Lassogen is the result of a convergence of technical advances that have opened the door to a vast, new, untapped source of novel medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Burk
VP - Bus. Development
Hiroko Masamune
Browse more venture capital transactions:
Prev: 10/14/2020: Praemo venture capital transaction
Next: 10/14/2020: NinjaCat venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs